全文获取类型
收费全文 | 7628篇 |
免费 | 470篇 |
国内免费 | 362篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 54篇 |
妇产科学 | 45篇 |
基础医学 | 2348篇 |
口腔科学 | 77篇 |
临床医学 | 617篇 |
内科学 | 1191篇 |
皮肤病学 | 162篇 |
神经病学 | 367篇 |
特种医学 | 193篇 |
外国民族医学 | 3篇 |
外科学 | 481篇 |
综合类 | 1091篇 |
现状与发展 | 2篇 |
预防医学 | 163篇 |
眼科学 | 120篇 |
药学 | 728篇 |
中国医学 | 37篇 |
肿瘤学 | 770篇 |
出版年
2024年 | 11篇 |
2023年 | 83篇 |
2022年 | 118篇 |
2021年 | 164篇 |
2020年 | 131篇 |
2019年 | 170篇 |
2018年 | 183篇 |
2017年 | 182篇 |
2016年 | 171篇 |
2015年 | 170篇 |
2014年 | 235篇 |
2013年 | 573篇 |
2012年 | 213篇 |
2011年 | 245篇 |
2010年 | 197篇 |
2009年 | 198篇 |
2008年 | 216篇 |
2007年 | 247篇 |
2006年 | 227篇 |
2005年 | 236篇 |
2004年 | 234篇 |
2003年 | 242篇 |
2002年 | 205篇 |
2001年 | 190篇 |
2000年 | 210篇 |
1999年 | 173篇 |
1998年 | 200篇 |
1997年 | 207篇 |
1996年 | 230篇 |
1995年 | 244篇 |
1994年 | 265篇 |
1993年 | 220篇 |
1992年 | 245篇 |
1991年 | 248篇 |
1990年 | 201篇 |
1989年 | 158篇 |
1988年 | 155篇 |
1987年 | 128篇 |
1986年 | 105篇 |
1985年 | 258篇 |
1984年 | 182篇 |
1983年 | 92篇 |
1982年 | 70篇 |
1981年 | 16篇 |
1980年 | 6篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有8460条查询结果,搜索用时 0 毫秒
1.
2.
O. Morris M. Fairclough J. Grigg C. Prenant A. McMahon 《Journal of labelled compounds & radiopharmaceuticals》2019,62(1):4-23
Affinity peptide and protein‐ (APP) based radiotracers are an increasingly popular class of radiotracer in positron emission tomography (PET), which was once dominated by the use of small molecule radiotracers. Radiolabelled monoclonal antibodies (mAbs) are important examples of APPs, yet a preference for smaller APPs, which exhibit fast pharmacokinetics and permit rapid PET aided diagnosis, has become apparent. 18F exhibits favourable physical characteristics for APP radiolabelling and has been described as an ideal PET radionuclide. Notwithstanding, 18F radiolabelling of APP is challenging, and this is echoed in the literature where a number of diverse approaches have been adopted. This review seeks to assess and compare the approaches taken to 18F APP radiolabelling with the intention of highlighting trends within this expanding field. Generic themes have emerged in the literature, namely the use of mild radiolabelling conditions, a preference of site‐specific methodologies with an impetus for short, automated procedures which produce high‐yielding [18F]APPs. 相似文献
3.
Erika Cecon Anna Ivanova Marine Luka Florence Gbahou Anne Friederich Jean‐Luc Guillaume Patrick Keller Klaus Knoch Raise Ahmad Philippe Delagrange Michele Solimena Ralf Jockers 《Journal of pineal research》2019,66(2)
Melatonin receptors play important roles in the regulation of circadian and seasonal rhythms, sleep, retinal functions, the immune system, depression, and type 2 diabetes development. Melatonin receptors are approved drug targets for insomnia, non‐24‐hour sleep‐wake disorders, and major depressive disorders. In mammals, two melatonin receptors (MTRs) exist, MT1 and MT2, belonging to the G protein‐coupled receptor (GPCR) superfamily. Similar to most other GPCRs, reliable antibodies recognizing melatonin receptors proved to be difficult to obtain. Here, we describe the development of the first monoclonal antibodies (mABs) for mouse MT1 and MT2. Purified antibodies were extensively characterized for specific reactivity with mouse, rat, and human MT1 and MT2 by Western blot, immunoprecipitation, immunofluorescence, and proximity ligation assay. Several mABs were specific for either mouse MT1 or MT2. None of the mABs cross‐reacted with rat MTRs, and some were able to react with human MTRs. The specificity of the selected mABs was validated by immunofluorescence microscopy in three established locations (retina, suprachiasmatic nuclei, pituitary gland) for MTR expression in mice using MTR‐KO mice as control. MT2 expression was not detected in mouse insulinoma MIN6 cells or pancreatic beta‐cells. Collectively, we report the first monoclonal antibodies recognizing recombinant and native mouse melatonin receptors that will be valuable tools for future studies. 相似文献
4.
目的建立单抗N糖分析方法的系统适用性对照品,并设定相应的系统适用性要求。方法利用液质联用(LC-MS)仪对N糖系统适用性对照品进行N糖型的表征鉴别,并对对照品进行稳定性评价。结合方法特点和验证数据,对系统适用性要求进行设定。结果建立的系统适用性对照品具有良好的稳定性,其糖型涵盖了单抗主要的N糖型种类。针对3种药典拟收录的单抗N糖分析方法,设定了以下系统适用性要求,包括:图谱与典型图谱相似、G1F(1,6)和G1F(1,3)的分离度应满足具体要求、G0F%应在规定的范围内、G0F保留时间的RSD应≤4%。结论建立了单抗N糖系统适用性对照品,可配合3种2020年版《中国药典》拟收录的N糖分析方法使用。 相似文献
5.
Excretory/secretory antigen of Toxocara canis: recognition profiles of polyclonal and larvicidal monoclonal antibodies 总被引:1,自引:1,他引:0
Summary Five monoclonal antibodies against the excretory/secretory (E/S) antigen of Toxocara canis were obtained and characterized. Immunoprecipitating activity was demonstrated in an in-vitro micropre-cipitating assay using live T. canis larvae. Their capacity to kill larvae was also shown in an in-vitro assay. Two zones of reactivity were observed in 7.5 and 12.5% SDS-PAGE (177-77 kD, 43-15 kD) of immunoprecipitates of human and mouse positive polyclonal anlisera. The murine monoclonal antibodies showed a common pattern of reactivity with the proteins in the 177-77 kD range. 相似文献
6.
The distribution in renal tumours of 3-fucosyl-N-acetyl lactosamine has been studied by using the monoclonal antibodies AGF 4.36 and AGF 4.48 and immunoperoxidase methods on tissue sections. Seven of 19 nephroblastomas and 12 of 30 renal cell carcinomas contained the epitope. In nephroblastomas the epitope was found on the terminals of type B tubules in six cases and in one case on the type A or neoplastic tubules. In renal carcinoma the antigen was found on the surface of tumour cells. The results suggest that in kidneys bearing nephroblastomas ureteric bud elements may grow into the tumour from the adjacent kidney. 相似文献
7.
目的 观察共刺激分子阻断剂CD80单克隆抗体(CD80mAb)在协同未成熟树突细胞(imDC)诱导同种异体大鼠胰十二指肠移植免疫耐受中的作用。方法 建立糖尿病大鼠胰十二指肠移植动物模型;4E5杂交瘤细胞株BABIMC小鼠腹腔注射,抽取腹水,分离纯化后获得CD80mAb;分离供体大鼠骨髓来源DC细胞前体,经GM—CSF、IL-4体外刺激后。再加入IL-10共培养,鉴定为imDC;移植前7d,将2×10^6imDC经静脉途径注射至受体体内,同时分别给予生理盐水1ml、CD80mAb5mg连续14d。结果 四组受体大鼠移植后中位生存时间分别为12.7d、32.4d、50.2d、92.0d,实验组存活时间明显延长;组织学观察发现移植后7dCD80mAb+imDC组移植物形态尚完整,淋巴细胞浸润减少;混合淋巴细胞反应证实移植后7dCD80mAb+imDC组供受体间呈低反应性。结论 共刺激分子阻断剂CD80mAb能够协同imDC诱导受体T细胞对移植物的免疫耐受,降低宿主对移植物的急、慢性排斥反应,延长移植物的存活时间。 相似文献
8.
The value of MCA, CA 15-3, CEA and CA-125 for discrimination between metastatic breast cancer and adenocarcinoma of other primary sites 总被引:1,自引:0,他引:1
MCA, CA 15-3, CEA and CA 125 were determined in the serum of 49 patients with metastatic breast cancer and 38 patients with metastatic adenocarcinoma of other primary sites. By using the 99th percentile of the normal value distribution as the cut-off point, the positive predictive value (PV+) was found to be 85% (95% CI 76-94) for MCA, and 71% (95% CI 61-81) for CA 15-3. When receiver-operating-characteristic (ROC) curves were constructed, the PV+ for CA 15-3 was increased to 82% (95% CI 72-92), using 60 U ml-1 as the cut-off point. With the exception of two patients who had a slightly elevated MCA, MCA and CA 15-3 identified the same patients with breast cancer. By combining a positive MCA or CA 15-3 with a negative CEA and CA 125, further improvement of the PV+ could be achieved; 100% (95% CI 91-100). We conclude that MCA and CA 15-3 may play a useful role in discrimination between patients with metastatic breast cancer and those with adenocarcinoma of other primary sites. 相似文献
9.
Sandra V Navarra 《Nephrology, dialysis, transplantation》2006,21(3):579-581
Systemic lupus erythematosus (SLE) is a complex disease whichhas posed a continuing challenge to scientists and cliniciansof diverse areas of specialization. It serves as a model forthe study of the mechanisms of autoimmunityprovidingan important basis for the development of novel targeted therapiesin lupus and related conditions. The pathophysiology of SLE stems from the abnormal clearanceof apoptotic cells and/or endothelial activation. Material fromdying cells such as apoptotic blebs that are not efficientlyremoved may act as antigenic stimuli and lead to the developmentof autoantibodies with consequent formation of immune complexesand an inflammatory response in a variety of organ systems [1].This 相似文献
10.
本文对以重组淋球菌IgA蛋白酶为抗原制备的7株特异性McAb的特性进行了初步研究。结果有5株(1C8、1E5、1F11、1G3和2E6)能中和淋球菌IgA蛋白酶活性。经相加试验初步证明,其中1F11、2G3与其它3株McAb的作用位点不同。因此,淋球菌IgA蛋白酶至少存在3个中和表位。 相似文献